ConclusionFondaparinux Na was a safe and effective treatment for NSTEMI.

结论磺达肝癸钠治疗非st段抬高急性冠脉综合征安全有效。

Conclusions: Excess adiposity is strongly related to first NSTEMI occurring prematurely.

结论：过度肥胖与过早发生初发nstemi显著相关。

Early revascularization was associated with a similar improvement in long-term outcomes for both STEMI and NSTEMI.

早期再血管化在改善STEMI和NSTEMI的长期结果方面结果相似。

Objective to conclude the diagnostic experience in NSTEMI in15cases for fear that to improve the diagnostic accuracy.

目的总结15例nste MI的诊断体会，以提高诊断的正确性。

The CRUSADE initiative included high-risk patients with unstable angina and non–ST-segment elevation myocardial infarction (NSTEMI).

CRUSADE入选包括高危不稳定性心绞痛和非ST段抬高心梗患者。

Objective: To observe the clinical effect and safety in treatment of non-ST elevation myocardial infarction (NSTEMI) with clopidogrel.

目的：观察氯吡格雷治疗急性非st段抬高心肌梗死(NSTEMI)的临床疗效及安全性。

Acute coronary syndrome (ACS) includes unstable angina (UA), non-ST segment elevated myocardial infarction (NSTEMI) and st segment elevated myocardial infarction (STEMI).

急性冠脉综合征(ACS)包括不稳定心绞痛(UA)、非st段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)。

Baseline prediction of bleeding risk can complement ischemic risk prediction for optimization of NSTEMI care; however, existing models are not well suited for this purpose.

出血风险的基线预测因素可完善缺血风险的预测，优化NSTEMI治疗，但现有模型不太适用于此目的。

These data suggest that in clinical investigations of early revascularization among patients with NSTEMI, extended follow-up may be necessary to demonstrate treatment benefit.

这些资料提示在NSTEMI患者的早期再血管化的临床研究中，延长随访时间对于验证治疗获益是必要的。

Objective To investigate the rapid determination of brain natriuretic peptide (BNP) in the early diagnosis of non-ST-segment elevation acute myocardial infarction (NSTEMI) value.

目的探讨快速测定脑钠肽(BNP)在早期诊断非st段抬高急性心肌梗死(NSTEMI)中的价值。

Objective:To study the characteristics of arrhythmias in patients with acute ST segment elevation myocardial infarction(STEMI) and non-ST segment elevation myocardial infarction(NSTEMI).

目的：对比分析急性ST段抬高性心肌梗死与非ST段抬高性心肌梗死患者并发心律失常的特点。

The monofactor analysis shows:the past history of angina and diabetes mellitus are the predicting risk factors of major cardiovascular event in the 6- month follow-up in NSTEMI patients.

单因素分析显示，冠心病病史和糖尿病是NSTEMI患者6个月发生心血管事件的危险因子。